News Conference News TCT 2024 Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick Yael L. Maxwell November 07, 2024
News Conference News TCT 2021 NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy L.A. McKeown October 22, 2021
News Conference News TCT 2020 MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant? Shelley Wood October 16, 2020
Presentation TCT 2017 Editorial Perspective: End-stage HF Treatment: Time for An Interventional Approach? Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Daniel Burkhoff October 31, 2017
Presentation TCT 2017 MitraClip for End-stage Heart Failure and Cardiogenic Shock Presenter: James B. Hermiller Jr., Ralph Stephan von Bardeleben, Saibal Kar October 30, 2017
Presentation TCT 2017 Case #3: MitraClip in a Patient With End-stage Heart Failure and Severe Functional MR (With Discussion) Presenter: Saibal Kar, Scott Lim, Olaf Franzen October 30, 2017
Presentation TCT 2016 What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? Stop Wasting Valuable Time Go Straight to LVAD/Transplant! Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Nir Uriel October 30, 2016
Presentation TCT 2016 What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? MitraClip Should Always Be Considered First! Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Saibal Kar October 30, 2016
Presentation TCT 2015 In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer. Presenter: Nabil Dib, Philippe Menasché, Marc S. Penn October 15, 2015
Presentation TCT 2015 In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One! Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry October 15, 2015
Presentation TCT 2015 In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key! Presenter: Nabil Dib, Philippe Menasché, Jay H Traverse October 15, 2015
Presentation TCT 2015 In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key! Presenter: Nabil Dib, Philippe Menasché, Amit Patel October 15, 2015